ATE491155T1 - Verfahren und kits zur erkennung und messung von adamts13/fx1-komplexen - Google Patents
Verfahren und kits zur erkennung und messung von adamts13/fx1-komplexenInfo
- Publication number
- ATE491155T1 ATE491155T1 AT08003179T AT08003179T ATE491155T1 AT E491155 T1 ATE491155 T1 AT E491155T1 AT 08003179 T AT08003179 T AT 08003179T AT 08003179 T AT08003179 T AT 08003179T AT E491155 T1 ATE491155 T1 AT E491155T1
- Authority
- AT
- Austria
- Prior art keywords
- adamts13
- kits
- complexes
- measurement
- detection
- Prior art date
Links
- 102000043853 ADAMTS13 Human genes 0.000 title abstract 4
- 108091005670 ADAMTS13 Proteins 0.000 title abstract 4
- 238000001514 detection method Methods 0.000 title 1
- 238000005259 measurement Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 2
- 238000002965 ELISA Methods 0.000 abstract 1
- 108010074864 Factor XI Proteins 0.000 abstract 1
- 208000024659 Hemostatic disease Diseases 0.000 abstract 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 201000007023 Thrombotic Thrombocytopenic Purpura Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
- 230000001732 thrombotic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96486—Metalloendopeptidases (3.4.24)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/709,562 US20080138837A1 (en) | 2004-07-19 | 2007-02-22 | Methods and kits for detecting and measuring ADAMTS13/FXI complexes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE491155T1 true ATE491155T1 (de) | 2010-12-15 |
Family
ID=39253849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08003179T ATE491155T1 (de) | 2007-02-22 | 2008-02-21 | Verfahren und kits zur erkennung und messung von adamts13/fx1-komplexen |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20080138837A1 (de) |
| EP (1) | EP1962091B1 (de) |
| AT (1) | ATE491155T1 (de) |
| DE (1) | DE602008003850D1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2566963T3 (es) * | 2007-11-21 | 2016-04-18 | Oregon Health & Science University | Anticuerpos monoclonales anti-factor XI y métodos de uso de los mismos |
| TR201904662T4 (tr) | 2008-12-18 | 2019-05-21 | Gruber Andras | Anti-fxı antikorları ve kullanma yöntemleri. |
| ES2554231T3 (es) * | 2011-05-19 | 2015-12-17 | Baxalta Incorporated | Detección de complejos de ADAMTS13-anticuerpo en circulación |
| EP2847228B1 (de) | 2012-05-10 | 2018-07-25 | Bayer Pharma Aktiengesellschaft | Zur bindung an den gerinnungsfaktor xi und/oder dessen aktivierten form faktor xia fähige antikörper und verwendungen davon |
| BR102015016451A2 (pt) * | 2015-07-08 | 2017-03-28 | Univ Fed Do Rio Grande Do Sul | uso de plaquetas, processo de detecção e/ou de rastreamento, kit de detecção e/ou de rastreamento |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340934A (en) * | 1989-11-03 | 1994-08-23 | The United States Of Americas As Represented By The Secretary Of Health & Human Services | CDNA sequences of human bone matrix proteins |
| US6242246B1 (en) * | 1997-12-15 | 2001-06-05 | Somalogic, Inc. | Nucleic acid ligand diagnostic Biochip |
| US20030083231A1 (en) * | 1998-11-24 | 2003-05-01 | Ahlem Clarence N. | Blood cell deficiency treatment method |
| US20010049106A1 (en) * | 2000-04-27 | 2001-12-06 | Leonard Buckbinder | ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| US6926894B2 (en) * | 2000-11-22 | 2005-08-09 | Baxter Aktiengesellschaft | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
| JP2003284570A (ja) * | 2001-04-25 | 2003-10-07 | Chemo Sero Therapeut Res Inst | フォンビルブラント因子（ｖＷＦ）切断酵素 |
| US7037658B2 (en) * | 2001-08-16 | 2006-05-02 | Regents Of University Of Michigan | Methods and compositions for detecting variant ADAMTS13 genes |
| US20040138187A1 (en) * | 2002-08-28 | 2004-07-15 | Reading Christopher L. | Therapeutic treatment methods |
| CN1898567A (zh) * | 2003-12-22 | 2007-01-17 | 株式会社三菱化学药得论 | 通过测定冯维勒布兰德因子分解酶检测血栓症的方法 |
| US20050186646A1 (en) * | 2004-01-26 | 2005-08-25 | Cruz Miguel A. | Rapid assay to detect ADAMTS-13 activity |
| US7270976B2 (en) * | 2004-07-19 | 2007-09-18 | American Diagnostica, Inc. | Methods for measuring ADAMTS13 activity and protein on platelets and in plasma |
-
2007
- 2007-02-22 US US11/709,562 patent/US20080138837A1/en not_active Abandoned
-
2008
- 2008-02-21 AT AT08003179T patent/ATE491155T1/de not_active IP Right Cessation
- 2008-02-21 DE DE602008003850T patent/DE602008003850D1/de active Active
- 2008-02-21 EP EP08003179A patent/EP1962091B1/de not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| US20080138837A1 (en) | 2008-06-12 |
| DE602008003850D1 (de) | 2011-01-20 |
| EP1962091A1 (de) | 2008-08-27 |
| EP1962091B1 (de) | 2010-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0618713B8 (pt) | cardiolipina modificada e seus usos | |
| CY1121291T1 (el) | Ανοσοδοκιμασιες ενισχυσης σηματος | |
| NZ629703A (en) | Methods and compositions for detecting multiple analytes with a single signal | |
| DE602005013957D1 (de) | Verfahren zur durchführung von vollbluttests | |
| TW200942619A (en) | Apparatus and method for electrochemical detection | |
| EP4361609A3 (de) | Signalkodierung und -dekodierung in multiplexierten biochemischen assays | |
| HK1205764A1 (en) | Tuberculosis biomarkers and uses thereof | |
| ATE548467T1 (de) | Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände | |
| ATE491155T1 (de) | Verfahren und kits zur erkennung und messung von adamts13/fx1-komplexen | |
| IN2014CN01787A (de) | ||
| ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| RU2013118341A (ru) | Получение сыворотки | |
| EA201390638A8 (ru) | Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения | |
| ATE549624T1 (de) | Verfahren und zusammensetzungen zur diagnose und behandlung von grippe | |
| DE602004021281D1 (de) | Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren | |
| MX2016013462A (es) | Metodos y dispositivos para deteccion de resistencia a un inhibidor de enzima. | |
| MX2015003740A (es) | Metodo para evaluar la reaccion de coagulacion sanguinea. | |
| DE602006011756D1 (de) | Komplexformierungs- und -trennungsverfahren | |
| ATE441860T1 (de) | Verfahren und kits zur messung von adamts13/fxi- komplexen | |
| SG10201908265UA (en) | L-fabp immunoassay method and assay reagent used in said method | |
| Mancini et al. | Measurement of anti‐ADAMTS13 neutralizing autoantibodies: a comparison between CBA and FRET assays | |
| ATE452990T1 (de) | Verfahren zur zählung und identifikation von mikroorganismen | |
| EP2565647A4 (de) | Reagens zum testen eines antikörpers gegen treponema pallidum | |
| ATE468536T1 (de) | Verfahren zur messung von adamts13-aktivität auf der blutplättchenoberfläche. | |
| DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |